Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
IFF heads into its November earnings with short sellers pulling back sharply and at least one analyst marking up their view, yet the stock itself is drifting lower on the month.
The most striking development this week is how aggressively short sellers have retreated. Short interest has fallen nearly 29% over the past month, dropping from above 20 million shares in late August to 14.3 million, bringing the position down to 5.6% of the free float. The retreat has been steady and consistent through September, not a single-day event. The lending market reflects the same story: availability is loose at 306%, meaning there are roughly three shares available to borrow for every one already lent out, well above the 52-week trough of 188% hit on September 18. Cost to borrow has also eased, now at 0.42%, off roughly 14% from a month ago. This is not a market under pressure from the short side. Options positioning reinforces the picture: the put/call ratio at 0.77 is slightly below its 20-day average of 0.80, a fractionally call-skewed posture that is modest but not defensive. Taken together, the borrow market and options together describe a stock where the structural negative bet has been actively unwound.
The Street has noticed. Argus Research raised its price target from $85 to $95 this morning, maintaining a Buy, and the move is the freshest signal from the analyst community. That lifts the mean target to $96.24, roughly 15% above where the stock closed on Tuesday at $83.92. The broader direction of analyst moves over the past two months has been upward: Barclays lifted its Overweight target to $96 after the August results, Benchmark nudged its Buy target to $105, and Morgan Stanley moved to $95 in late June. UBS held Neutral but raised its target to $91, a signal that even the cautious camp sees less downside than before. The main tension on the Street runs between bulls pointing to improving return on capital (rising from 2.77% to 5.32% over the past year) and bears flagging projected revenue contraction of around 5.6% over the next twelve months following portfolio divestitures. Factor scores are mixed: dividend quality ranks in the 77th percentile, but EPS surprise sits at just the 17th percentile and the 90-day EPS momentum rank is only 12. The valuation is not demanding: the stock trades at 22x trailing earnings with an EV/EBITDA around 16.4x, both relatively stable over the past week.
The ownership picture carries one detail worth noting. Director Paul Fribourg made an open-market purchase of 273,500 shares on June 1 for approximately $20.3 million, at prices around $74. The stock is now roughly 13% above that entry. The CFO, Michael DeVeau, sold 8,825 shares in early August at $85.55, a discretionary sale without a 10b5-1 plan attached. The net insider position over the 90-day window as of mid-August is a net purchase of roughly $19 million, dominated entirely by the Fribourg buy. No activist is on the 13D register. The largest holder, Dodge & Cox, held 14.5% as of June 30 and has been a steady buyer, while Invesco added over 1.4 million shares through September, a more recent and notable accumulation.
The ORTEX short score has drifted from around 61 in late September to 57.8 today, moving away from the middle of the range and toward a less bearish read. Retail attention, measured by Wikipedia page views against IFF's own 90-day history, is running about 1.5 standard deviations below normal, suggesting the stock is not drawing fresh crowd interest at current levels.
The next focus is the November 5 earnings print. Recent history shows the stock moved down 2.5% the day after the August 2026 release, then recovered less than five days later, while an earlier 2026 release produced a 4.5% gain on the day. The range of single-day earnings reactions has been wide, from just under negative 2.5% to positive 9.3%. With short sellers having reduced their exposure materially going into the quarter, the asymmetry of surprise reactions will be worth watching closely as the date approaches.
See the live data behind this article on ORTEX.
Open IFF on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.